Company profile: Abionic
1.1 - Company Overview
Company description
- Provider of point-of-care diagnostic solutions at the boundaries of medical technology, biotechnology and nanotechnology, including abioSCOPE for rapid, accurate results from a single drop of blood; PSP Sepsis Test using Pancreatic Stone Protein for early sepsis detection; saliva-based SARS-CoV-2 antigen test; aeroallergen specific IgE panel; ferritin test for iron deficiency; and cSOFA COVID-19 severity score for triage and management.
Products and services
- PSP Sepsis Test: A biomarker-based test for early detection of sepsis using Pancreatic Stone Protein, producing results up to 72 hours before clinical signs appear
- AbioSCOPE: A point-of-care diagnostic platform that delivers rapid, accurate results from a single drop of blood, requiring minimal training and maintenance
- IVD CAPSULE Aeroallergen: A blood-based test diagnosing allergic asthma and rhinitis by measuring specific IgE levels for 7 key allergens
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Abionic
Ashvattha Therapeutics
HQ: United States
Website
- Description: Provider of clinical-stage precision nanomedicines and PET imaging agents, developing D-4517.2 for wet AMD and DME, OP-801 targeting CNS macrophages/microglia as a biomarker of neuroinflammation, OP-101 to modulate inflammatory cell activity in severe COVID-19 and other inflammatory diseases, and CSF1R Dendranib, a CSF1R tyrosine kinase inhibitor for multiple sclerosis.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ashvattha Therapeutics company profile →
Ondine Biomedical
HQ: Canada
Website
- Description: Provider of non-antibiotic, anti-infective therapies for bacterial, viral, and fungal infections, including Steriwave nasal decolonization that eradicates pathogens in minutes (MRSA, SARS-CoV-2), Photodisinfection using a photosensitive agent and non-thermal laser light to destroy pathogens without resistance, and an Expanded Access Program for investigational medicines prior to regulatory approval.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ondine Biomedical company profile →
Aethlon Medical
HQ: United States
Website
- Description: Provider of immunotherapeutic technologies to combat infectious disease and cancer, including the Hemopurifier, a device designed to rapidly remove cancer-promoting exosomes and circulating viruses from the bloodstream, currently under clinical trials for various cancers and viral infections.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Aethlon Medical company profile →
Cavidi
HQ: Sweden
Website
- Description: Provider of HIV viral load monitoring diagnostics and BOLD-based immunoassay signal amplification solutions, including Exazym reagent kits for attomole-level biomarker detection (up to 100x amplification), ClickChem conjugation, polymerase reaction and biotin detection kits, plus research services and collaborations on low-abundance biomarker discovery and immunoassay development.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cavidi company profile →
Quick-Med Technologies
HQ: United States
Website
- Description: Provider of proprietary, broad-based life sciences technologies.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Quick-Med Technologies company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Abionic
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Abionic
2.2 - Growth funds investing in similar companies to Abionic
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Abionic
4.2 - Public trading comparable groups for Abionic
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →